Surprisingly, while its pro-tumorigenic role has been demonstrated in other hematological cancers, notably acute myeloid leukemia (AML), knowledge of the specific role of p300 in T-ALL pathogenesis is limited. Here, EP300 is linked to hematopoietic and lymphoid cell neoplasm.